Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Williams

Showing results (211-220 of 417) with videos related to

Pageof 42
Sort By:
Hypertension (Dallas, Tex. : 1979)|April 30, 2019
Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes MellitusFaisal Rahman, John W McEvoy, Toshiaki Ohkuma, et al.
Journal of Medicinal Chemistry|June 17, 2021
Development of [<sup>18</sup>F]AldoView as the First Highly Selective Aldosterone Synthase PET Tracer for Imaging of Primary HyperaldosteronismKerstin Sander, Thibault Gendron, Klaudia A Cybulska, et al.
Diabetes, Obesity & Metabolism|May 4, 2019
Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trialElizabeth Selvin, Dan Wang, John William McEvoy, et al.
European Journal of Preventive Cardiology|August 31, 2013
Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysisBillingsley Kaambwa, Stirling Bryan, Sue Jowett, et al.
European Heart Journal|June 7, 2024
Office measurement vs. ambulatory blood pressure monitoring: associations with mortality in patients with or without diabetesMichael Böhm, Alejandro de la Sierra, Felix Mahfoud, et al.
Lancet (London, England)|September 6, 2017
Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical studyWilko Spiering, Bryan Williams, Jan Van der Heyden, et al.
European Heart Journal|February 6, 2014
High prevalence of masked uncontrolled hypertension in people with treated hypertensionJosé R Banegas, Luis M Ruilope, Alejandro de la Sierra, et al.
Journal of Hypertension|April 1, 2011
A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronismHari K Parthasarathy, Joel Ménard, William B White, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 24, 2012
The risk of cancer in people with diabetes and chronic kidney diseaseGermaine Wong, Sophia Zoungas, Serigne Lo, et al.
Arthritis and Rheumatism|April 29, 2006
"Endogenous adjuvant" activity of the RNA components of lupus autoantigens Sm/RNP and Ro 60Kindra M Kelly, Haoyang Zhuang, Dina C Nacionales, et al.
Pageof 42

Showing results (211-220 of 417) with videos related to

Sort By:
Pageof 42
Hypertension (Dallas, Tex. : 1979)|April 30, 2019
Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes MellitusFaisal Rahman, John W McEvoy, Toshiaki Ohkuma, et al.
Journal of Medicinal Chemistry|June 17, 2021
Development of [<sup>18</sup>F]AldoView as the First Highly Selective Aldosterone Synthase PET Tracer for Imaging of Primary HyperaldosteronismKerstin Sander, Thibault Gendron, Klaudia A Cybulska, et al.
Diabetes, Obesity & Metabolism|May 4, 2019
Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trialElizabeth Selvin, Dan Wang, John William McEvoy, et al.
European Journal of Preventive Cardiology|August 31, 2013
Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysisBillingsley Kaambwa, Stirling Bryan, Sue Jowett, et al.
European Heart Journal|June 7, 2024
Office measurement vs. ambulatory blood pressure monitoring: associations with mortality in patients with or without diabetesMichael Böhm, Alejandro de la Sierra, Felix Mahfoud, et al.
Lancet (London, England)|September 6, 2017
Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical studyWilko Spiering, Bryan Williams, Jan Van der Heyden, et al.
European Heart Journal|February 6, 2014
High prevalence of masked uncontrolled hypertension in people with treated hypertensionJosé R Banegas, Luis M Ruilope, Alejandro de la Sierra, et al.
Journal of Hypertension|April 1, 2011
A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronismHari K Parthasarathy, Joel Ménard, William B White, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 24, 2012
The risk of cancer in people with diabetes and chronic kidney diseaseGermaine Wong, Sophia Zoungas, Serigne Lo, et al.
Arthritis and Rheumatism|April 29, 2006
"Endogenous adjuvant" activity of the RNA components of lupus autoantigens Sm/RNP and Ro 60Kindra M Kelly, Haoyang Zhuang, Dina C Nacionales, et al.
Pageof 42